EGFR Resisters Announcements/Updates

*March 2025* Abstract Introduction The treatment landscape for people diagnosed with EGFR-mutated (EGFR-m) NSCLC has rapidly evolved, yet there remains limited self-reported information about the lived experience. In this paper, we describe the clinical characteristics and treatment experiences of people living with EGFR-m lung cancer from Project PRIORITY, a patient-driven…

*February 2025* The EGFR Resisters Research Summit is an annual event focusing on the advancement of EGFRm treatment paradigms through meaningful collaboration between physician scientist investigators and patients. This special newsletter includes a summit recap and covers its agenda, including the Awardees and their research projects: Dr. Catherine Meador, Detecting Small Cell Transformation in…

*December 2025* The EGFR Resisters and CEC Oncology just held the sixth annual EGFR Resisters Research Summit December 12th and 13th in Louisville, Kentucky. We brought together young investigators from all across the country who are doing work related to EGFR positive lung cancer. And as in the past, we…